Artificial intelligence and neuropsychological measures: The case of Alzheimer's disease.
Petronilla Battista, Christian Salvatore, Manuela Berlingeri...
https://pubmed.ncbi.nlm.nih.gov/32437744/Actively Recruiting
Led by Istituti Clinici Scientifici Maugeri SpA · Updated on 2026-11-03
200
Participants Needed
1
Research Sites
39 weeks
Total Duration
Researchers are studying how artificial intelligence AI can help analyze language and speech patterns in people with various neurodegenerative diseases, including Alzheimers disease, Primary Progressive Aphasia, frontotemporal dementia, Lewy body dementia, and Parkinsons disease. The goal is to find objective language markers that can improve early and accurate diagnosis, which is challenging with current methods. This study involves Italian-speaking participants and aims to create a reliable AI-based tool that supports personalized treatment and clinical decision-making. Participants will take part in a one-time remote speech and language assessment conducted via a secure video platform. During this 1.5-hour session, they will complete tasks like describing images and other language and cognitive tests. The spoken data collected will be processed using AI and machine learning techniques, including automatic speech recognition and natural language processing models such as BERT, RoBERTa, and UmBERTo. These methods help extract detailed linguistic and semantic features for analysis. Participants include patients with neurodegenerative diseases and healthy controls. The study measures how well AI-based language analysis can distinguish between different diagnostic groups immediately after the assessment. Researchers will use machine learning classifiers and explainable AI techniques to understand the diagnostic decisions. The study also collects demographic and clinical data to ensure accurate comparisons. Overall, it aims to build the first structured Italian language database for these disorders, supporting future research and clinical use.
CONDITIONS
Automated Language Analysis in Neurodegenerative Diseases: Application of Artificial Intelligence Models
P
Petronilla Battista, PhD
G
Gaia C Santi, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Istituti Clinici Scientifici Maugeri SpA
Lead Sponsor
Università degli studi di Trieste
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (remote)
Duration - 1.5 hours
Participants complete a one-time remote speech and language evaluation including spontaneous speech tasks and cognitive tests. Audio data is recorded and analyzed using AI techniques.
1 session (remote)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Petronilla Battista, Christian Salvatore, Manuela Berlingeri...
https://pubmed.ncbi.nlm.nih.gov/32437744/Simona Aresta, Petronilla Battista, Cinzia Palmirotta...
https://pubmed.ncbi.nlm.nih.gov/40550806/Cinzia Palmirotta, Simona Aresta, Petronilla Battista...
https://pubmed.ncbi.nlm.nih.gov/38391712/Istituti Clinici Scientifici Maugeri SpA
Lead Sponsor
Università degli studi di Trieste
Collaborating Sponsor